Adrenergic beta2‐selective blocker in isoprenaline‐enhanced essential tremor
- 1 January 1987
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 2 (2), 103-108
- https://doi.org/10.1002/mds.870020204
Abstract
A beta2‐selective adrenergic‐receptor‐blocking drug, ICI 118.551,150 mg/day, prevented almost as effectively as the nonselective antagonist propranolol, 240 mg/day, the isoprenaline enhancement of essential tremor amplitude.Keywords
This publication has 10 references indexed in Scilit:
- Atenolol vs. propranolol in essential tremor A controlled, quantitative studyActa Neurologica Scandinavica, 2009
- Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremorActa Neurologica Scandinavica, 1986
- Adrenergic beta-receptor sensitivity in essential tremor.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Beta-blockers in isoproterenolenhanced essential tremorActa Neurologica Scandinavica, 1984
- Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man.British Journal of Clinical Pharmacology, 1983
- Essential TremorClinical Neuropharmacology, 1983
- Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- BETA-ADRENOCEPTOR ANTAGONISTS AND ESSENTIAL TREMORThe Lancet, 1981
- A Standardized Isoproterenol Sensitivity TestArchives of Internal Medicine, 1972